Article Text

Download PDFPDF
CASE REPORT
High-dose anakinra as treatment for macrophage activation syndrome caused by refractory Kawasaki disease in an infant

Footnotes

  • Contributors ML-H has been in charge of the writing process of this case report and made changes to the manuscript. She has made the figure regarding the laboratory findings and MAS criteria and the submission and resubmission. UBH supported with the information on genetic and immune deficiency investigation and contributed with grammar correction. AEC has been supportive with knowledge of expert level and supported with input on the focus of this case report. She was responsible for the correction of language and grammar.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent for publication Parental/guardian consent obtained.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors ML-H has been in charge of the writing process of this case report and made changes to the manuscript. She has made the figure regarding the laboratory findings and MAS criteria and the submission and resubmission. UBH supported with the information on genetic and immune deficiency investigation and contributed with grammar correction. AEC has been supportive with knowledge of expert level and supported with input on the focus of this case report. She was responsible for the correction of language and grammar.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent for publication Parental/guardian consent obtained.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.